Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IPIC -- Ignore unavailable to you. Want to Upgrade?

To: margaret foley who wrote (1085)	3/10/1998 10:20:00 AM
From: charles feicht	Read Replies (1) \| Respond to of 1359

I apologize in advance for what may be a stupid question, but I have not visited this site for weeks. Question is this: What's up with citicoline? Any news at all about what's holding up it's release? Appreciate any update. Charles

To: margaret foley who wrote (1085)	3/19/1998 11:25:00 AM
From: cardiologist to be	Read Replies (1) \| Respond to of 1359

finished residency in chicago in 97 moving to detroit for fellowship. starts 7/1/98 and ends either 6/30/01 or 6/30/02 depending on whether i do an interventional year or not. hope ipic does well after aha meeting this month. if it doubles or better, may be able to avoid moonlighting as a fellow. btw, as i have posted earlier, while i have some minor doubts about ipic, i believe the combination of ceraxon, bucindolol, and positive news out of aha about redux and valve damage, could easily lead to a doubling or tripling of this stock price in six to twelve months. just like avei from 5/97 to 12/97. check out angn. it may be to defibrillators and rf ablation catheters what avei was to stents. adios.